By Debdeep Gupta | 15 Sep, 2025
Alembic Pharma shares gain on EIR from USFDA for Panelav unit
Alembic Pharmaceuticals share price rose in the opening trade on September 15 following the company received establishment inspection report (EIR) post inspection by the US Food and Drug Administration (USFDA).At 09:20am, Alembic Pharmaceuticals was quoting at Rs 953.90, up Rs 8.10, or 0.86 percent, on the BSE.".... has EIR today for the inspection carried out conducted from 26th May, 2025 to 31st...
Live Comments
TechyInvestor01 2024-09-21 16:37:47
All retail investor should be alloted shares at specific cut off rate and not at different price and that too on same date. Who has to control this type of fraud played under rules of SEBI
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2022-08-25 20:09:08
47
Login & Reply Like(0) Dislike(0) Repost Spam